ATA airs concerns about DEA’s proposed special telehealth registration
The U.S. Drug Enforcement Agency’s proposed rule to establish special registrations for providers and telemedicine platforms to prescribe certain schedules of controlled substances without requiring an in-person doctor’s visit requires “meaningful” clarification and adjustments,…
Continue Reading